Iron catalyzed oxidation of benzylic alcohols to benzoic acids.

The bidentate N,O-ligands phenol-pyrazole (HL1), naphthol-pyrazole (HL2) and the commercially available ligand 5-methylphenol-benzotriazole (HL3) were used for the synthesis of novel iron(iii) complexes. The mononuclear iron complexes [FeCl(L1)2] (1), [FeCl(L2)2] (2) and [FeCl(L3)2] (3) are stable to air and moisture, both in the solid state as well as in solution, while the dinuclear, μ-oxido bridged complex [{Fe(L1)2}2(μ-O)] (1a) is air sensitive. All four complexes 1, 2, 3 and 1a were investigated for their catalytic activity in the direct one-pot oxidation of primary alcohols to carbonic acids with 30% aq.

Dioxomolybdenum(VI) complexes with pyrazole based aryloxide ligands: synthesis, characterization and application in epoxidation of olefins.

Synthesis, characterization, and epoxidation chemistry of four new dioxomolybdenum(VI) complexes [MoO(2)(L)(2)] (1-4) with aryloxide-pyrazole ligands L = L1-L4 is described. Catalysts 1-4 are air and moisture stable and easy to synthesize in only three steps in good yields. All four complexes are coordinated by the two bidentate ligands in an asymmetric fashion with one phenoxide and one pyrazole being trans to oxo atoms, respectively.

Oxorhenium(V) complexes with pyrazole based aryloxide ligands and application in olefin epoxidation.

We synthesized and characterized a set of new oxorhenium(V) complexes coordinated by various pyrazole containing phenol (L1-L3) and naphthol ligands (L4-L7). Depending on the starting material, we were able to selectively synthesize monosubstituded or disubstituted complexes of the type [ReOBr(2)L(PPh(3))] (1-7; L = L1-L7) and [ReOClL(2)] (L = L1 8; L2 9; L4 10; L6 11), respectively. All complexes are stable to air and moisture, both in solid state as well as in solution.

Oxorhenium(V) complexes with ketiminato ligands: coordination chemistry and epoxidation of cyclooctene.

Rhenium(V) oxo complexes of the type [ReOX(L)(2)] (1-7; X = Cl, Br) containing beta-ketiminate ligands (L = CH(3)C(O)CH(2)C(NAr)CH(3): Ar = Ph (APOH), 2-MePh (MPOH), 2,6-Me(2)Ph (DPOH), 2,6-(i)Pr(2)Ph (DiPOH)) have been prepared by reaction of [ReOX(3)(OPPh(3))(SMe(2))] (X = Cl, Br) with the lithium salts of the corresponding ligands. All compounds have been spectroscopically characterized, showing [ReOX(DiPO)(2)] (X = Cl (1), Br (5)), [ReOX(DPO)(2)] (X = Cl (2), Br (6)), and [ReOX(APO)(2)] (X = Cl (4), Br (7)) to be isomerically pure, in contrast to complex [ReOCl(MPO)(2)] (3), which exhibits a mixture of isomers. Compounds 2, 3, 5, and 7 were crystallographically characterized, showing similar octahedral coordination spheres with trans O horizontal lineRe-O and cis O horizontal lineRe-Cl bonds.

Determination of selenosugars in crude human urine using high-performance liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry.

The narrow gap between essentiality and toxicity of selenium requires detailed investigations on selenium metabolism in order to find suitable indicators for the selenium status in the human body. Current methods for quantitative selenium speciation in human urine are based on separation by high-performance liquid chromatography (HPLC) coupled online with elemental mass spectrometry (MS), and the potential of molecular MS detection techniques for the reliable identification and quantification of selenosugars in crude human urine has not been utilized. Now we report the development of an HPLC tandem mass spectrometric (MS/MS) method for the reliable determination in crude human urine of three significant selenium urinary metabolites, collectively termed selenosugars, namely methyl 2-acetamido-2-deoxy-1-seleno-beta-D-galactopyranoside (SeGalNAc), methyl 2-acetamido-2-deoxy-1-seleno-beta-D-glucopyranoside (SeGluNAc) and methyl 2-amino-2-deoxy-1-seleno-beta-D-galactopyranoside (SeGalNH2).

Novel thioarsenic metabolites in human urine after ingestion of an arsenosugar, 2',3'-dihydroxypropyl 5-deoxy-5-dimethylarsinoyl-beta-D-riboside.

The presence of arsenic-containing carbohydrates, arsenosugars, in many seafoods raises questions of human health concerning the ingestion and metabolism of these compounds. A previous study investigating the metabolites in human urine after the ingestion of a common arsenosugar 2',3'-dihydroxypropyl 5-deoxy-5-dimethylarsinoyl-beta-d-riboside (oxo-arsenosugar) showed that the arsenic was rapidly excreted in the urine and was present as at least 12 metabolites, only three of which could be identified. In this repeat study with oxo-arsenosugar and using high-performance liquid chromatography/inductively coupled plasma mass spectrometry, we report the identification of seven arsenic metabolites, which together accounted for 88% of the total urinary arsenic collected over 61 h.

Selenium metabolites in human urine after ingestion of selenite, L-selenomethionine, or DL-selenomethionine: a quantitative case study by HPLC/ICPMS.

To obtain quantitative information on human metabolism of selenium, we have performed selenium speciation analysis by HPLC/ICPMS on samples of human urine from one volunteer over a 48-hour period after ingestion of selenium (1.0 mg) as sodium selenite, L-selenomethionine, or DL-selenomethionine. The three separate experiments were performed in duplicate.